Robust production of infectious viral particles in Huh-7 cells by introducing mutations in hepatitis C virus structural proteins
|
journal
|
September 2007 |
Virologic response and characterisation of HCV genotype 2–6 in patients receiving TMC435 monotherapy (study TMC435-C202)
|
journal
|
March 2013 |
Hepatitis C Virus E2 Envelope Glycoprotein Core Structure
|
journal
|
November 2013 |
Mutation of juxtamembrane cysteines in the tetraspanin CD81 affects palmitoylation and alters interaction with other proteins at the cell surface
|
journal
|
July 2009 |
AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility
|
journal
|
December 2009 |
Improved prediction of protein side-chain conformations with SCWRL4
|
journal
|
December 2009 |
CD81 is dispensable for hepatitis C virus cell-to-cell transmission in hepatoma cells
|
journal
|
January 2009 |
Safety and on-treatment efficacy of telaprevir: the early access programme for patients with advanced hepatitis C
|
journal
|
November 2013 |
Sofosbuvir for the treatment of hepatitis C virus
|
journal
|
October 2013 |
Virtual screening with AutoDock Vina and the common pharmacophore engine of a low diversity library of fragments and hits against the three allosteric sites of HIV integrase: participation in the SAMPL4 protein–ligand binding challenge
|
journal
|
February 2014 |
Patterns and Trends in Antipsychotic Prescribing for Parkinson Disease Psychosis
|
journal
|
July 2011 |
Lentiviral vectors pseudotyped with a modified RD114 envelope glycoprotein show increased stability in sera and augmented transduction of primary lymphocytes and CD34+ cells derived from human and nonhuman primates
|
journal
|
August 2002 |
Identification of Conserved Residues in the E2 Envelope Glycoprotein of the Hepatitis C Virus That Are Critical for CD81 Binding
|
journal
|
August 2006 |
RNA Interference and Single Particle Tracking Analysis of Hepatitis C Virus Endocytosis
|
journal
|
December 2009 |
AS2TS system for protein structure modeling and analysis
|
journal
|
July 2005 |
CD81 and Hepatitis C Virus (HCV) Infection
|
journal
|
February 2014 |
Biogenesis of hepatitis C virus envelope glycoproteins
|
journal
|
November 2001 |
Structural properties of the ectodomain of hepatitis C virus E2 envelope protein
|
journal
|
January 2009 |
Characterisation of bacterially expressed structural protein E2 of hepatitis C virus
|
journal
|
September 2004 |
Pattern of expression of tetraspanin antigen genes in Burkitt lymphoma cell lines
|
journal
|
December 2001 |
(−)-Epigallocatechin-3-gallate is a new inhibitor of hepatitis C virus entry
|
journal
|
February 2012 |
Role of N-Linked Glycans in the Functions of Hepatitis C Virus Envelope Proteins Incorporated into Infectious Virions
|
journal
|
September 2010 |
Exosome-mediated transmission of hepatitis C virus between human hepatoma Huh7.5 cells
|
journal
|
July 2013 |
Advantages of a single-cycle production assay to study cell culture-adaptive mutations of hepatitis C virus
|
journal
|
March 2008 |
Expression, purification, immunological characterization and application of Escherichia coli-derived hepatitis C virus E2 proteins
|
journal
|
October 2001 |
The Transmembrane Domains of Hepatitis C Virus Envelope Glycoproteins E1 and E2 Play a Major Role in Heterodimerization
|
journal
|
May 2000 |
Delineation of Regions Important for Heteromeric Association of Hepatitis C Virus E1 and E2
|
journal
|
April 1997 |
Broadly neutralizing antibodies protect against hepatitis C virus quasispecies challenge
|
journal
|
December 2007 |
The Natural Killer Cell Response to HCV Infection
|
journal
|
January 2013 |
The Neutralizing Activity of Anti-Hepatitis C Virus Antibodies Is Modulated by Specific Glycans on the E2 Envelope Protein
|
journal
|
May 2007 |
Short-Range Exosomal Transfer of Viral RNA from Infected Cells to Plasmacytoid Dendritic Cells Triggers Innate Immunity
|
journal
|
October 2012 |
Folding and dimerization of hepatitis C virus E1 and E2 glycoproteins in stably transfected CHO cells
|
journal
|
February 2005 |
EWI-2wint promotes CD81 clustering that abrogates Hepatitis C Virus entry: Dynamics and partitioning of CD81
|
journal
|
February 2013 |
Real-time imaging of hepatitis C virus infection using a fluorescent cell-based reporter system
|
journal
|
January 2010 |
Analysis of Hepatitis C Virus Capsid, E1, and E2/NS1 Proteins Expressed in Insect Cells
|
journal
|
November 1993 |
In vitro assay for neutralizing antibody to hepatitis C virus: Evidence for broadly conserved neutralization epitopes
|
journal
|
November 2003 |
The antimalarial ferroquine is an inhibitor of hepatitis C virus
|
journal
|
May 2013 |
Production of infectious hepatitis C virus in tissue culture from a cloned viral genome
|
journal
|
June 2005 |
Systematic Studies with Amoxapine,
a New Antidepressant
|
journal
|
January 1982 |
Characterization of Antibodies Induced by Vaccination with Hepatitis C Virus Envelope Glycoproteins
|
journal
|
September 2010 |
Dissecting the role of putative CD81 binding regions of E2 in mediating HCV entry: Putative CD81 binding region 1 is not involved in CD81 binding
|
journal
|
January 2008 |
Structure of the core ectodomain of the hepatitis C virus envelope glycoprotein 2
|
journal
|
February 2014 |
Rapid acute treatment of agitation in patients with bipolar I disorder: a multicenter, randomized, placebo-controlled clinical trial with inhaled loxapine: Inhaled loxapine for bipolar disorder
|
journal
|
February 2012 |
A quantitative test to estimate neutralizing antibodies to the hepatitis C virus: cytofluorimetric assessment of envelope glycoprotein 2 binding to target cells.
|
journal
|
March 1996 |
High-Level Expression, Single-Step Immunoaffinity Purification and Characterization of Human Tetraspanin Membrane Protein CD81
|
journal
|
June 2008 |
Different Requirements for Scavenger Receptor Class B Type I in Hepatitis C Virus Cell-Free versus Cell-to-Cell Transmission
|
journal
|
May 2013 |
The CD81 Partner EWI-2wint Inhibits Hepatitis C Virus Entry
|
journal
|
April 2008 |
Diverse CD81 Proteins Support Hepatitis C Virus Infection
|
journal
|
August 2006 |
A Novel Monoclonal Anti-CD81 Antibody Produced by Genetic Immunization Efficiently Inhibits Hepatitis C Virus Cell-Cell Transmission
|
journal
|
May 2013 |
Summary of the Comparative Effectiveness Review on Off-Label Use of Atypical Antipsychotics
|
journal
|
June 2012 |
Acute hepatitis C virus infection: A chronic problem
|
journal
|
December 2007 |
Hepatitis C virus cell-cell transmission in hepatoma cells in the presence of neutralizing antibodies
|
journal
|
October 2007 |
AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading
|
journal
|
January 2009 |
Cianopramine and amitriptyline in the treatment of depressed patients ? a placebo-controlled study
|
journal
|
January 1985 |
Multimeric HCV E2 protein obtained from pichia pastoris cells induces a strong immune response in mice
|
journal
|
March 2007 |
CD81 protein is expressed at high levels in normal germinal center B cells and in subtypes of human lymphomas
|
journal
|
February 2010 |
Perspectives for the utilization of neutralizing human monoclonal antibodies as anti-HCV drugs
|
journal
|
August 2008 |
Small molecule inhibition of hepatitis C virus E2 binding to CD81
|
journal
|
September 2003 |
The sensitivity and specificity of the MTS tetrazolium assay for detecting the in vitro cytotoxicity of 20 chemicals using human cell lines
|
journal
|
December 1997 |
Hepatitis C Virus Glycoprotein E2 Contains a Membrane-proximal Heptad Repeat Sequence That Is Essential for E1E2 Glycoprotein Heterodimerization and Viral Entry
|
journal
|
May 2004 |
Immunization of Human Volunteers With Hepatitis C Virus Envelope Glycoproteins Elicits Antibodies That Cross-Neutralize Heterologous Virus Strains
|
journal
|
September 2011 |
Hepatitis C Virus Entry Depends on Clathrin-Mediated Endocytosis
|
journal
|
June 2006 |
Characterization of Hepatitis C Virus Recombinants with Chimeric E1/E2 Envelope Proteins and Identification of Single Amino Acids in the E2 Stem Region Important for Entry
|
journal
|
November 2012 |
Blocking Hepatitis C Virus Infection with Recombinant Form of Envelope Protein 2 Ectodomain
|
journal
|
August 2009 |
Characterization of the Envelope Glycoproteins Associated with Infectious Hepatitis C Virus
|
journal
|
July 2010 |
Hepatitis C Virus Entry Requires a Critical Postinternalization Step and Delivery to Early Endosomes via Clathrin-Coated Vesicles
|
journal
|
September 2006 |
Novel Function of CD81 in Controlling Hepatitis C Virus Replication
|
journal
|
January 2010 |
Characterization of hepatitis C virus envelope glycoprotein complexes expressed by recombinant vaccinia viruses.
|
journal
|
January 1993 |
Expression and identification of hepatitis C virus polyprotein cleavage products.
|
journal
|
January 1993 |
Formation and intracellular localization of hepatitis C virus envelope glycoprotein complexes expressed by recombinant vaccinia and Sindbis viruses.
|
journal
|
January 1994 |
Hepatitis C virus glycoprotein folding: disulfide bond formation and association with calnexin.
|
journal
|
January 1996 |
Formation of native hepatitis C virus glycoprotein complexes.
|
journal
|
January 1997 |
A Retention Signal Necessary and Sufficient for Endoplasmic Reticulum Localization Maps to the Transmembrane Domain of Hepatitis C Virus Glycoprotein E2
|
journal
|
March 1998 |
Characterization of Hepatitis C Virus E2 Glycoprotein Interaction with a Putative Cellular Receptor, CD81
|
journal
|
August 1999 |
Identification of Amino Acid Residues in CD81 Critical for Interaction with Hepatitis C Virus Envelope Glycoprotein E2
|
journal
|
April 2000 |
Identification of the Hepatitis C Virus E2 Glycoprotein Binding Site on the Large Extracellular Loop of CD81
|
journal
|
November 2002 |
Binding of the Hepatitis C Virus E2 Glycoprotein to CD81 Is Strain Specific and Is Modulated by a Complex Interplay between Hypervariable Regions 1 and 2
|
journal
|
February 2003 |
Characterization of Functional Hepatitis C Virus Envelope Glycoproteins
|
journal
|
February 2004 |
Role of N-Linked Glycans in the Functions of Hepatitis C Virus Envelope Glycoproteins
|
journal
|
June 2005 |
Building of the Tetraspanin Web: Distinct Structural Domains of CD81 Function in Different Cellular Compartments
|
journal
|
January 2006 |
Prevalence of active hepatitis C virus infections among general public of Lahore, Pakistan
|
journal
|
January 2013 |
Conserved peptides within the E2 region of Hepatitis C virus induce humoral and cellular responses in goats
|
journal
|
January 2009 |
Quetiapine monotherapy for bipolar depression
|
journal
|
March 2008 |
Elicitation of strong immune responses by a DNA vaccine expressing a secreted form of hepatitis C virus envelope protein E2 in murine and porcine animal models
|
journal
|
January 2006 |
Efficacy and Safety of Loxapine for Inhalation in the Treatment of Agitation in Patients With Schizophrenia: A Randomized, Double-Blind, Placebo-Controlled Trial
|
journal
|
January 2011 |